Answers are grounded in this paper and cite their sources.
Observational analysis reveals CD4 T cells enhance immune responses in rheumatoid arthritis, suggesting IGFL2 as a biomarker.
Human CD4 + T cells play a central role in the pathogenesis of autoimmune diseases, but their immunoregulatory mechanisms driving pathogenesis remain to be elucidated. We show that human T peripheral helper cells (T PH cells) regulate peripheral immune responses via insulin-like growth factor–like family member 2 (IGFL2), an inflammatory factor found exclusively in primates. Single-cell RNA sequencing of seropositive rheumatoid arthritis (RA) synovium showed that IGFL2 is specifically expressed by CD4 + T cells, predominantly T PH cells. IGFL2 promotes transforming growth factor–β–induced CXCL13 production in CD4 + T cells, activates nuclear factor κB signaling, and induces monocyte gene signatures like those of pathogenic macrophages. CRISPR-Cas9 knockout of IGFL2 in synovial T PH cells suppressed this gene signature in cocultured monocytes. Blood IGFL2 protein levels correlated with RA disease severity and could be used as a potential biomarker. These findings highlight the involvement of IGFL2 in RA pathogenesis, emphasizing how human T PH cells regulate local immune responses via IGFL2.
No takes yet. Share an insight, caveat, or question.
Murakami et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: